Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases-Development and validation of the honeycombing, traction bronchiectasis, and monocyte (HTM)-score.

Shao, Guangyu; Hawle, Patricia; Akbari, Kaveh; Horner, Andreas; Hintenberger, Rainer; Kaiser, Bernhard; Lamprecht, Bernd; Lang, David

Shao, Guangyu; Hawle, Patricia; Akbari, Kaveh; Horner, Andreas; Hintenberger, Rainer; Kaiser, Bernhard; Lamprecht, Bernd; Lang, David.

Afiliação

Shao G; Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Linz, Austria.
Hawle P; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
Akbari K; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
Horner A; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
Hintenberger R; Central Radiology Institute, Kepler University Hospital, Linz, Austria.
Kaiser B; Department of Internal Medicine 4 - Pneumology, Kepler University Hospital, Linz, Austria.
Lamprecht B; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
Lang D; Medical Faculty, Johannes Kepler University Linz, Linz, Austria.

Front Med (Lausanne) ; 9: 1043720, 2022.

Article em En | MEDLINE | ID: mdl-36465895

Palavras-chave

autoimmune disease; diffusion capacity (DL); forced vital capacity (FVC); honeycombing; idiopathic pulmonary fibrosis; lung fibrosis; monocyte count; traction bronchiectasis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article